ATC code J06

Last updated
ATC codes
J Antiinfectives for systemic use
J01 Antibacterials for systemic use
J02 Antimycotics for systemic use
J04 Antimycobacterials
J05 Antivirals for systemic use
Human only
J06 Immune sera and immunoglobulins
J07 Vaccines
ATCvet only
QJ51 Antibacterials for intramammary use
QJ54 Antimycobacterials for intramammary use

ATCcodeJ06Immune sera and immunoglobulins is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. [1] [2] Subgroup J06 is part of the anatomical group J Antiinfectives for systemic use. [3]

Contents

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

J06A Immune sera

J06AA Immune sera

J06AA01 Diphtheria antitoxin
J06AA02 Tetanus antitoxin
J06AA03 Snake venom antiserum
J06AA04 Botulinum antitoxin
J06AA05 Gas-gangrene sera
J06AA06 Rabies serum

J06B Immunoglobulins

J06BA Immunoglobulins, normal human

J06BA01 Immunoglobulins, normal human, for extravascular administration
J06BA02 Immunoglobulins, normal human, for intravascular administration

J06BB Specific immunoglobulins

J06BB01 Anti-D (rh) immunoglobulin
J06BB02 Tetanus immunoglobulin
J06BB03 Varicella/zoster immunoglobulin
J06BB04 Hepatitis B immunoglobulin
J06BB05 Rabies immunoglobulin
J06BB06 Rubella immunoglobulin
J06BB07 Vaccinia immunoglobulin
J06BB08 Staphylococcus immunoglobulin
J06BB09 Cytomegalovirus immunoglobulin
J06BB10 Diphtheria immunoglobulin
J06BB11 Hepatitis A immunoglobulin
J06BB12 Encephalitis, tick-borne immunoglobulin
J06BB13 Pertussis immunoglobulin
J06BB14 Morbilli immunoglobulin
J06BB15 Parotitis immunoglobulin
J06BB16 Palivizumab
J06BB17 Motavizumab
J06BB18 Raxibacumab
J06BB19 Anthrax immunoglobulin
J06BB21 Bezlotoxumab
J06BB22 Obiltoxaximab
J06BB30 Combinations

J06BC Other immunoglobulins

J06BC01 Nebacumab

J06BD Antiviral monoclonal antibodies

J06BD01 Palivizumab
J06BD02 Motavizumab
J06BD04 Ansuvimab [4]
J06BD05 Sotrovimab [4]
J06BD06 Regdanvimab [4]
J06BD07 Casirivimab and imdevimab [4]
J06BD08 Nirsevimab [4]

Notes

1. ^ ATC codes J06BD04 to J06BD08 are temporary, and will only become official after the 1st of January, 2022.

See also

Related Research Articles

The Anatomical Therapeutic Chemical (ATC) Classification System is a drug classification system that classifies the active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties. Its purpose is an aid to monitor drug use and for research to improve quality medication use. It does not imply drug recommendation or efficacy. It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC), and was first published in 1976.

ATC code JAntiinfectives for systemic use is a section of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.

ATC code A02Drugs for acid related disorders is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup A02 is part of the anatomical group A Alimentary tract and metabolism.

ATC code A10Drugs used in diabetes is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup A10 is part of the anatomical group A Alimentary tract and metabolism.

ATC code B02Antihemorrhagics is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup B02 is part of the anatomical group B Blood and blood forming organs.

ATC code C01Cardiac therapy is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup C01 is part of the anatomical group C Cardiovascular system.

ATC code C03Diuretics is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup C03 is part of the anatomical group C Cardiovascular system.

ATC code C05Vasoprotectives is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup C05 is part of the anatomical group C Cardiovascular system.

ATC code D06Antibiotics and chemotherapeutics for dermatological use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup D06 is part of the anatomical group D Dermatologicals.

ATC code H01Pituitary and hypothalamic hormones and analogues is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup H01 is part of the anatomical group H Systemic hormonal preparations, excluding sex hormones and insulins.

ATC code H03Thyroid therapy is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup H03 is part of the anatomical group H Systemic hormonal preparations, excluding sex hormones and insulins.

ATC code J02Antimycotics for systemic use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup J02 is part of the anatomical group J Antiinfectives for systemic use.

ATC code J07Vaccines is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup J07 is part of the anatomical group J Antiinfectives for systemic use.

ATC code L02Endocrine therapy is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup L02 is part of the anatomical group L Antineoplastic and immunomodulating agents.

ATC code L04Immunosuppressants is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup L04 is part of the anatomical group L Antineoplastic and immunomodulating agents.

ATC code M03Muscle relaxants is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup M03 is part of the anatomical group M Musculo-skeletal system.

ATC code N01Anesthetics is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup N01 is part of the anatomical group N Nervous system.

ATC code N04Anti-parkinson drugs is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup N04 is part of the anatomical group N Nervous system.

ATC code N07Other nervous system drugs is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup N07 is part of the anatomical group N Nervous system.

ATC code P01Antiprotozoals is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup P01 is part of the anatomical group P Antiparasitic products, insecticides and repellents.

References

  1. "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health . Retrieved 2020-02-01.
  2. "ATC-Klassifikation mit definierten Tagesdosen DDD" (in German). German Institute for Medical Documentation and Information . Retrieved 2020-02-01.
  3. "ATC/DDD Index 2021: code J06". WHO Collaborating Centre for Drug Statistics Methodology.
  4. 1 2 3 4 5 "New ATC 5th levels". WHO Collaborating Centre for Drug Statistics Methodology. 24 November 2021. Retrieved 28 November 2021.